Beroni Group (NSX:BTG) - Stock Price, News & Analysis

BTG Stock Overview

Develops and sells smoking control products, air purifiers, water filters, cosmetics, stem-cell therapies, and health care products and supplements in Australia and internationally. More details

BTG fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	5/6
Dividends	0/6

Risk Analysis

Earnings have declined by 21% per year over past 5 years

Shares are highly illiquid

Does not have a meaningful market cap (A$76M)

Does not have meaningful revenue (A$2M)

Beroni Group Limited Competitors

PYC Therapeutics

ASX:PYC

AU$886.6m

Actinogen Medical

ASX:ACW

AU$73.6m

Radiopharm Theranostics

ASX:RAD

AU$56.5m

Amplia Therapeutics

ASX:ATX

AU$24.7m

Price History & Performance

Summary of all time highs, changes and price drops for Beroni Group
Historical stock prices
Current Share Price	AU$0.99
52 Week High	AU$0.99
52 Week Low	AU$0.99
Beta	0.14
11 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
33 Year Change	n/a
5 Year Change	n/a
Change since IPO	160.53%

Recent updates

Shareholder Returns

	BTG	AU Biotechs	AU Market
7D	0%	-3.6%	1.5%
1Y	n/a	10.0%	17.2%

Return vs Industry: Insufficient data to determine how BTG performed against the Australian Biotechs industry.

Return vs Market: Insufficient data to determine how BTG performed against the Australian Market.

Price Volatility

Is BTG's price volatile compared to industry and market?
BTG volatility
BTG Average Weekly Movement	n/a
Biotechs Industry Average Movement	9.7%
Market Average Movement	8.6%
10% most volatile stocks in AU Market	17.3%
10% least volatile stocks in AU Market	3.4%

Stable Share Price: BTG has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine BTG's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2014	n/a	Jacky Zhang	www.beronigroup.com

Beroni Group Limited, together with its subsidiaries, develops and sells smoking control products, air purifiers, water filters, and health care products and supplements in China, Australia, the United States, and Japan. It operates through Nicobloc, Fogibloc Air Purifier, Olansi Water Filter, Health Supplements, Cosmetic products, and Viral Diagnostic Kits segments. The company’s products include NicoBloc, a smoking cessation/harm reduction product; and Fogibloc, an air purifier system.

Beroni Group Limited Fundamentals Summary

How do Beroni Group's earnings and revenue compare to its market cap?
BTG fundamental statistics
Market cap	AU$75.87m
Earnings (TTM)	-AU$4.45m
Revenue (TTM)	AU$1.91m

39.8x

P/S Ratio

-17.0x

P/E Ratio

Is BTG overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BTG income statement (TTM)
Revenue	AU$1.91m
Cost of Revenue	AU$424.61k
Gross Profit	AU$1.48m
Other Expenses	AU$5.93m
Earnings	-AU$4.45m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)	-0.058
Gross Margin	77.73%
Net Profit Margin	-233.47%
Debt/Equity Ratio	7.9%

How did BTG perform over the long term?

See historical performance and comparison

Beroni Group NSX:BTG Stock Report